Compare ACIW & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACIW | LIVN |
|---|---|---|
| Founded | 1975 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 3.5B |
| IPO Year | 1996 | 2015 |
| Metric | ACIW | LIVN |
|---|---|---|
| Price | $40.99 | $64.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $62.50 | ★ $72.43 |
| AVG Volume (30 Days) | 633.6K | ★ 771.9K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.09 | N/A |
| EPS | ★ 2.16 | N/A |
| Revenue | ★ $1,009,780,000.00 | N/A |
| Revenue This Year | $9.67 | $9.43 |
| Revenue Next Year | $7.41 | $6.85 |
| P/E Ratio | $18.99 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $38.05 | $32.48 |
| 52 Week High | $55.87 | $71.58 |
| Indicator | ACIW | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 51.54 | 54.46 |
| Support Level | $40.45 | $61.80 |
| Resistance Level | $43.01 | $65.25 |
| Average True Range (ATR) | 1.19 | 2.00 |
| MACD | 0.16 | 0.29 |
| Stochastic Oscillator | 81.93 | 96.89 |
ACI Worldwide Inc develops, markets, and installs a portfolio of software products focused on facilitating electronic payments. The firm's products are sold and supported directly and through distribution networks covering three geographic regions - the Americas, EMEA, and Asia Pacific. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but the majority of the revenue is generated in the United States and EMEA regions. The company's operating segment includes Payment Software and Biller. The company generates the majority of its revenue from the Payment Software segment.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.